We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Biosensor-Based Rapid Urine Test Detects Urogenital Schistosomiasis

By LabMedica International staff writers
Posted on 14 Jul 2015
Print article
Image: Egg of Schistosoma haematobium in a wet mount of urine concentrates, showing the characteristic terminal spine (Photo courtesy of Centers for Disease Control and Prevention).
Image: Egg of Schistosoma haematobium in a wet mount of urine concentrates, showing the characteristic terminal spine (Photo courtesy of Centers for Disease Control and Prevention).
In infrastructure-limited regions, point-of-care (POC) molecular diagnostics hold the potential to transform the management of infectious diseases such as schistosomiasis that carry significant long-term morbidity if left undiagnosed.

Electrochemical biosensors are well suited for molecular diagnostics because of their high sensitivity, low cost, ease of integration into POC devices, and portability of the reader instrumentation and have now been used to detect urogenital schistosomiasis.

Scientists at Stanford University School of Medicine (CA, USA) and their colleagues have developed a strategy for a rapid one hour molecular diagnosis of bacterial urinary tract infections using electrochemical biosensors. Urinary cells are lysed and directly applied to an array of sensors functionalized with oligonucleotide probes targeting the 16S ribosomal ribonucleic acid (rRNA) of common uropathogens. Formation of the sequence-specific hybridization complex between the pathogen rRNA and the labeled capture and detector probe pairs is detected by an enzyme tag that mediates an amperometric signal output.

The biosensor is composed of three planar gold electrodes, one each for working, auxiliary, and reference. For the biosensor assay, capture probes are bound to the surface of the working electrode via a thiol linkage. Cells in the sample are lysed and mixed with a buffered solution of detector probe, then applied to the sensor surface. If the target rRNA is present, a hybridization complex of target, capture, and detector probes forms. This complex is detected by binding of horseradish peroxidase (HRP)-conjugated anti-fluorescein binding to a fluorescein tag on the detector probe and addition of tetramethylbenzidine (TMB) substrate. The electron transport mediated by the HRP is measured amperometerically, and the signal is proportional to the quantity of the target.

By inducing bulk fluid motion and local heating, alternating current (AC) electrokinetics improved overall signal-to-noise of the biosensor assay. Further implementation of electrokinetics will facilitate integration into a POC device as it obviates the need for an external incubator for hybridization. For schistosomal detection, the scientists applied square wave AC potential across the working and auxiliary electrodes of the electrochemical sensors using a function generator.

The authors concluded that they have made an important step toward development of a POC device for rapid detection of Schistosoma haematobium eggs in urine. They have implemented strategies that will aid in device integration, such as mechanical lysis and AC electrokinetics. For future development, they will integrate this core assay into a fully automated microfluidics cartridge, further optimize the detection sensitivity, and validate with clinical samples.

Related Links:

Stanford University School of Medicine



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.